Ming-Feng Hou Selected Research

tacedinaline (CI 994)

1/2022

Epigenetic therapy combination of UNC0638 and CI-994 suppresses breast cancer via epigenetic remodeling of BIRC5 and GADD45A.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ming-Feng Hou Research Topics

Disease

148	Breast Neoplasms (Breast Cancer) 09/2022 - 07/2002
125	Neoplasms (Cancer) 09/2022 - 02/2002
32	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2003
15	Triple Negative Breast Neoplasms 03/2022 - 01/2014
15	Carcinogenesis 01/2021 - 11/2005
9	Lymphatic Metastasis 01/2019 - 06/2006
6	Carcinoma (Carcinomatosis) 11/2020 - 10/2011
6	Colorectal Neoplasms (Colorectal Cancer) 06/2013 - 07/2002
5	Inflammation (Inflammations) 09/2017 - 01/2004
4	Mouth Neoplasms (Oral Cancer) 05/2022 - 08/2019
4	Pain (Aches) 04/2021 - 11/2012
4	Stomach Neoplasms (Stomach Cancer) 03/2015 - 05/2003
4	Melanoma (Melanoma, Malignant) 11/2013 - 06/2004
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 09/2015 - 06/2004
3	Dermatitis 01/2015 - 10/2006
3	Squamous Cell Carcinoma of Head and Neck 02/2013 - 02/2012
2	Disease Progression 01/2020 - 03/2010
2	Autoimmune Diseases (Autoimmune Disease) 01/2019 - 06/2014

Drug/Important Bio-Agent (IBA)

28	Estrogen ReceptorsIBA 01/2022 - 05/2006
21	Proteins (Proteins, Gene)FDA Link 07/2021 - 01/2006
20	Biomarkers (Surrogate Marker)IBA 01/2022 - 04/2009
17	Hormones (Hormone)IBA 01/2022 - 05/2006
10	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2022 - 11/2005
10	Progesterone Receptors (Progesterone Receptor)IBA 01/2018 - 06/2006
9	EnzymesIBA 06/2017 - 01/2003
7	Pharmaceutical PreparationsIBA 01/2022 - 12/2013
7	ErbB Receptors (EGF Receptor)IBA 01/2020 - 01/2012
6	Phosphotransferases (Kinase)IBA 05/2022 - 06/2006
6	AdipokinesIBA 11/2020 - 06/2006
6	Tamoxifen FDA LinkGeneric 01/2020 - 11/2002
6	Transcription Factors (Transcription Factor)IBA 01/2020 - 10/2011
6	DNA (Deoxyribonucleic Acid)IBA 09/2016 - 02/2002
6	FlavonoidsIBA 02/2016 - 12/2010
5	Superoxides (Superoxide)IBA 05/2022 - 01/2004
5	Biological ProductsIBA 01/2022 - 08/2011
5	Messenger RNA (mRNA)IBA 01/2022 - 01/2006
5	phthalic acid (phthalate)IBA 01/2022 - 08/2012
5	Nicotinamide PhosphoribosyltransferaseIBA 11/2020 - 09/2011
5	Cadherins (E-Cadherin)IBA 02/2018 - 05/2006
5	MicroRNAs (MicroRNA)IBA 01/2016 - 01/2013
5	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 07/2014 - 04/2008
4	AntioxidantsIBA 04/2022 - 11/2005
4	CytokinesIBA 12/2019 - 11/2011
4	IntegrinsIBA 12/2019 - 02/2013
4	Conditioned Culture MediaIBA 01/2019 - 06/2014
4	LipidsIBA 09/2017 - 01/2007
4	Tumor Biomarkers (Tumor Markers)IBA 04/2016 - 11/2009
4	Estrogens (Estrogen)FDA Link 10/2014 - 11/2002
3	ORALIT (ORS)IBA 09/2022 - 09/2015
3	CaspasesIBA 05/2022 - 02/2016
3	Annexin A5IBA 05/2022 - 06/2013
3	Acetylcysteine (Siran)FDA LinkGeneric 05/2022 - 02/2016
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 12/2015
3	Focal Adhesion Protein-Tyrosine KinasesIBA 11/2021 - 02/2011
3	UbiquitinIBA 09/2021 - 09/2009
3	Ligases (Synthetase)IBA 09/2021 - 09/2009
3	Phenobarbital (Luminal)FDA Link 01/2021 - 08/2018
3	LigandsIBA 01/2021 - 01/2014
3	RNA (Ribonucleic Acid)IBA 01/2021 - 08/2019
3	Metalloproteases (Metalloproteinases)IBA 11/2018 - 08/2009
3	human ERBB2 proteinIBA 01/2018 - 07/2006
3	CateninsIBA 01/2018 - 04/2013
3	AgarIBA 01/2017 - 06/2013
3	Interleukin-8 (Interleukin 8)IBA 03/2015 - 06/2013
3	InterleukinsIBA 03/2015 - 06/2013
3	CC ChemokinesIBA 02/2015 - 01/2014
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2014 - 04/2009
3	Matrix Metalloproteinases (MMPs)IBA 07/2013 - 08/2009
3	Epidermal Growth Factor (EGF)IBA 06/2013 - 12/2011
3	CalciumIBA 06/2013 - 01/2011
3	Codon (Codons)IBA 05/2013 - 05/2003
3	Nuclear Proteins (Protein, Nuclear)IBA 09/2012 - 01/2006
2	Cisplatin (Platino)FDA LinkGeneric 05/2022 - 10/2017
2	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 05/2022 - 09/2012
2	Sirolimus (Rapamycin)FDA Link 05/2022 - 02/2015
2	fucoidanIBA 05/2022 - 04/2022
2	Glutathione (Reduced Glutathione)IBA 04/2022 - 11/2006
2	2-methyl-5,6-cyclopentapyrimidineIBA 01/2022 - 11/2018
2	Monoclonal AntibodiesIBA 01/2022 - 01/2013
2	CreatinineIBA 01/2022 - 01/2003
2	Diethylhexyl Phthalate (DEHP)IBA 01/2022 - 02/2016
2	mono-(2-ethylhexyl)phthalateIBA 01/2022 - 11/2018
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2021 - 12/2019
2	LuciferasesIBA 11/2020 - 06/2013
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2019 - 06/2013
2	Glycoproteins (Glycoprotein)IBA 11/2018 - 02/2013
2	sinularinIBA 07/2018 - 04/2018
2	1-dodecylpyridoxal (PLD)IBA 06/2018 - 03/2016
2	AnthracyclinesIBA 06/2018 - 03/2016
2	liposomal doxorubicin (Doxil)FDA Link 06/2018 - 03/2016

Therapy/Procedure

34	Therapeutics 06/2022 - 01/2003
16	Drug Therapy (Chemotherapy) 01/2022 - 09/2006
14	Radiotherapy 06/2021 - 09/2006
5	Mastectomy (Mammectomy) 01/2020 - 09/2002
4	Adjuvant Chemotherapy 06/2018 - 03/2008
3	Mammaplasty (Breast Reconstruction) 12/2019 - 08/2002
3	Modified Radical Mastectomy (Mastectomy, Modified) 01/2016 - 08/2012
2	Chemoradiotherapy 03/2022 - 07/2021
2	Immunotherapy 01/2021 - 06/2014
2	Myocutaneous Flap 01/2020 - 09/2014